🇺🇸 FDA
Patent

US 7972598

VEGF-binding fusion proteins and therapeutic uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 7972598 (VEGF-binding fusion proteins and therapeutic uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/00, A61P, A61P27/00, A61P27/02